Contact
searchSearch
HMP Global

Diffuse Large B-Cell Lymphoma Resource Center

Diffuse Large B-Cell Lymphoma
Learning Library

New & Trending

EZH2
Rapid Refresh
Understanding the Role of EZH2 in Cancer Pathogenesis
02/28/2024
This animation explains the role of EZH2 in the regulation of cell growth and the effects of EZH2 overexpression.
This animation explains the role of EZH2 in the regulation of cell growth and the effects of EZH2 overexpression.
This animation explains the role...
02/28/2024
APP Institute Oncology
Oluwatobi Odetola, MD,
Conference Coverage
Promising Efficacy of Frontline Nivolumab in Combination With R-CHOP for Patients With High-Risk DLBCL
12/12/2023
Oluwatobi Odetola, MD
During the 2023 ASH Annual Meeting in San Diego, Oluwatobi Odetola, MD, shared data from a phase 1b study that evaluated the safety and efficacy of nivolumab in combination with R-CHOP in high-risk DLBCL.
During the 2023 ASH Annual Meeting in San Diego, Oluwatobi Odetola, MD, shared data from a phase 1b study that evaluated the safety and efficacy of nivolumab in combination with R-CHOP in high-risk DLBCL.
During the 2023 ASH Annual...
12/12/2023
Oncology
From Oncology
Narendranath Epperla, MD, MS
Conference Coverage
Analyzing Outcomes of Tafasitamab for the Treatment of R/R DLBCL Among Racial and Ethnic Minorities
12/11/2023
Narendranath Epperla, MD, MS
At the 2023 ASH Annual Meeting, Narendranath Epperla, MD, MS, presented a retrospective cohort study analyzing the patterns and outcomes of treatment with tafasitamab among patients with R/R diffuse large B-cell lymphoma across racial and...
At the 2023 ASH Annual Meeting, Narendranath Epperla, MD, MS, presented a retrospective cohort study analyzing the patterns and outcomes of treatment with tafasitamab among patients with R/R diffuse large B-cell lymphoma across racial and...
At the 2023 ASH Annual Meeting,...
12/11/2023
Oncology
From Oncology

Clinical Pearls

EZH2
Rapid Refresh
Understanding the Role of EZH2 in Cancer Pathogenesis
02/28/2024
This animation explains the role of EZH2 in the regulation of cell growth and the effects of EZH2 overexpression.
This animation explains the role of EZH2 in the regulation of cell growth and the effects of EZH2 overexpression.
This animation explains the role...
02/28/2024
APP Institute Oncology
Oluwatobi Odetola, MD,
Conference Coverage
Promising Efficacy of Frontline Nivolumab in Combination With R-CHOP for Patients With High-Risk DLBCL
12/12/2023
Oluwatobi Odetola, MD
During the 2023 ASH Annual Meeting in San Diego, Oluwatobi Odetola, MD, shared data from a phase 1b study that evaluated the safety and efficacy of nivolumab in combination with R-CHOP in high-risk DLBCL.
During the 2023 ASH Annual Meeting in San Diego, Oluwatobi Odetola, MD, shared data from a phase 1b study that evaluated the safety and efficacy of nivolumab in combination with R-CHOP in high-risk DLBCL.
During the 2023 ASH Annual...
12/12/2023
Oncology
Narendranath Epperla, MD, MS
Conference Coverage
Analyzing Outcomes of Tafasitamab for the Treatment of R/R DLBCL Among Racial and Ethnic Minorities
12/11/2023
Narendranath Epperla, MD, MS
At the 2023 ASH Annual Meeting, Narendranath Epperla, MD, MS, presented a retrospective cohort study analyzing the patterns and outcomes of treatment with tafasitamab among patients with R/R diffuse large B-cell lymphoma across racial and...
At the 2023 ASH Annual Meeting, Narendranath Epperla, MD, MS, presented a retrospective cohort study analyzing the patterns and outcomes of treatment with tafasitamab among patients with R/R diffuse large B-cell lymphoma across racial and...
At the 2023 ASH Annual Meeting,...
12/11/2023
Oncology
News
Remote Interventions Show Promise in Reducing Caregiver Distress During Hematopoietic Stem Cell Transplantation Support
09/19/2025
Emily Estrada
For caregivers of patients undergoing hematopoietic stem cell transplantation, remote accessible interventions may reduce stress and improve quality of life.
For caregivers of patients undergoing hematopoietic stem cell transplantation, remote accessible interventions may reduce stress and improve quality of life.
For caregivers of patients...
09/19/2025
APP Institute Oncology
News
Transfusion Algorithm Educating Providers on Correct Use of Specialty Blood Products May Lead to Decrease in Risk of GVHD in Outpatient Setting
09/15/2025
Emily Estrada
Use of a transfusion algorithm increased appropriate education on the use of cytomegalovirus-negative and irradiated blood products which may lower the risk of transfusion-associated GVHD among oncology providers in an outpatient clinic.
Use of a transfusion algorithm increased appropriate education on the use of cytomegalovirus-negative and irradiated blood products which may lower the risk of transfusion-associated GVHD among oncology providers in an outpatient clinic.
Use of a transfusion algorithm...
09/15/2025
APP Institute Oncology
Christa Marie Braun-Inglis, DNP, APRN, FNP-BC, AOCNP
Videos
Insights Into the Efficacy of Mentorship Programs in Improving Oncology Clinical Trial Enrollment
09/10/2025
Christa Marie Braun-Inglis, DNP, APRN, FNP-BC, AOCNP, shares the development and expansion of a structured mentorship program for advanced practice providers and clinical research coordinators in a community oncology setting.
Christa Marie Braun-Inglis, DNP, APRN, FNP-BC, AOCNP, shares the development and expansion of a structured mentorship program for advanced practice providers and clinical research coordinators in a community oncology setting.
Christa Marie Braun-Inglis, DNP,...
09/10/2025
APP Institute Oncology
News
APP Mentorship Model Improves Clinical Trial Accrual and Minority Participation in Community Oncology Setting
08/26/2025
Emily Estrada
A mentorship initiative demonstrated promising results in improving accrual to clinical trials and increasing participation among minority populations through the engagement of APPs and clinical research coordinators.
A mentorship initiative demonstrated promising results in improving accrual to clinical trials and increasing participation among minority populations through the engagement of APPs and clinical research coordinators.
A mentorship initiative...
08/26/2025
APP Institute Oncology
News
Establishing Best-Practice Workflows for Managing CRS With Bispecific Antibody Therapy in a Community Oncology Setting
08/20/2025
Emily Estrada
Researchers conducted an analysis to identify a framework for safely integrating novel immunotherapies into care settings while maintaining rapid response capacity for common immune-related toxicities like cytokine release syndrome.
Researchers conducted an analysis to identify a framework for safely integrating novel immunotherapies into care settings while maintaining rapid response capacity for common immune-related toxicities like cytokine release syndrome.
Researchers conducted an...
08/20/2025
APP Institute Oncology
Samantha Shenoy, NP, UCSF Health
Videos
Key Interventions for Patients on BCMA-Targeted Bispecific Antibody Therapy
08/12/2025
Samantha Shenoy, NP
Samantha Shenoy, NP, explains the treatment course of a patient diagnosed with kappa light chain myeloma and discusses key interventions when caring for a patient on BCMA-targeted bispecific antibody therapy.
Samantha Shenoy, NP, explains the treatment course of a patient diagnosed with kappa light chain myeloma and discusses key interventions when caring for a patient on BCMA-targeted bispecific antibody therapy.
Samantha Shenoy, NP, explains...
08/12/2025
APP Institute Oncology
How I Treat: RRMM
Treatment Decision-Making in Relapsed or Refractory Multiple Myeloma
Beth Faiman, CNP, PhD, Cleveland Clinic
Videos
Case 2: A Patient With Multi-Relapsed Multiple Myeloma
07/21/2025
Beth Faiman, CNP, PhD
Beth Faiman, CNP, PhD, discusses treatment decision-making for a patient with multiple myeloma whose disease relapsed through several lines of therapy.
Beth Faiman, CNP, PhD, discusses treatment decision-making for a patient with multiple myeloma whose disease relapsed through several lines of therapy.
Beth Faiman, CNP, PhD, discusses...
07/21/2025
APP Institute Oncology
Beth Faiman, CNP, PhD, Cleveland Clinic
Videos
Case 1: A Patient With Symptomatic Multiple Myeloma
07/21/2025
Beth Faiman, CNP, PhD
Beth Faiman, CNP, PhD, discusses treatment decision-making for a patient with symptomatic relapsed multiple myeloma.
Beth Faiman, CNP, PhD, discusses treatment decision-making for a patient with symptomatic relapsed multiple myeloma.
Beth Faiman, CNP, PhD, discusses...
07/21/2025
APP Institute Oncology

APP Perspectives

Lorinda Coombs
APP Perspectives
Myeloma Care: Patient and Advanced Practice Provider Perspectives
11/17/2023
Lorinda Coombs, PhD, CNS, FNP-BC
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS,...
11/17/2023
APP Institute Oncology

Conference Coverage

Oluwatobi Odetola, MD,
Conference Coverage
Promising Efficacy of Frontline Nivolumab in Combination With R-CHOP for Patients With High-Risk DLBCL
12/12/2023
Oluwatobi Odetola, MD
During the 2023 ASH Annual Meeting in San Diego, Oluwatobi Odetola, MD, shared data from a phase 1b study that evaluated the safety and efficacy of nivolumab in combination with R-CHOP in high-risk DLBCL.
During the 2023 ASH Annual Meeting in San Diego, Oluwatobi Odetola, MD, shared data from a phase 1b study that evaluated the safety and efficacy of nivolumab in combination with R-CHOP in high-risk DLBCL.
During the 2023 ASH Annual...
12/12/2023
Oncology
Narendranath Epperla, MD, MS
Conference Coverage
Analyzing Outcomes of Tafasitamab for the Treatment of R/R DLBCL Among Racial and Ethnic Minorities
12/11/2023
Narendranath Epperla, MD, MS
At the 2023 ASH Annual Meeting, Narendranath Epperla, MD, MS, presented a retrospective cohort study analyzing the patterns and outcomes of treatment with tafasitamab among patients with R/R diffuse large B-cell lymphoma across racial and...
At the 2023 ASH Annual Meeting, Narendranath Epperla, MD, MS, presented a retrospective cohort study analyzing the patterns and outcomes of treatment with tafasitamab among patients with R/R diffuse large B-cell lymphoma across racial and...
At the 2023 ASH Annual Meeting,...
12/11/2023
Oncology
David Spigel, MD, Sarah Cannon Research Institute
Videos
Molecular Assay May Predict Patients With Non-Small Cell Lung Cancer to Benefit From Adjuvant Therapy
06/16/2025
David Spigel, MD
David Spigel, MD, discusses the results of the AIM-HIGH trial to evaluating the predictive efficacy of a 14-gene expression profile in identifying stage Ia to IIa patients with non-squamous NSCLC who benefit from adjuvant therapy.
David Spigel, MD, discusses the results of the AIM-HIGH trial to evaluating the predictive efficacy of a 14-gene expression profile in identifying stage Ia to IIa patients with non-squamous NSCLC who benefit from adjuvant therapy.
David Spigel, MD, discusses the...
06/16/2025
APP Institute Oncology
Patrick Forde, MBBCh
Videos
Neoadjuvant Nivolumab Plus Chemotherapy Shows Long-Term Survival Benefit Among Patients With Resectable Non-Small Cell Lung Cancer
06/05/2025
Patrick Forde, MD
Patrick Forde, MBBCh, shares insights on the long-term overall survival benefit demonstrated by neoadjuvant nivolumab plus chemotherapy among patients with resectable non-small cell lung cancer, as seen in the CheckMate 816 trial.
Patrick Forde, MBBCh, shares insights on the long-term overall survival benefit demonstrated by neoadjuvant nivolumab plus chemotherapy among patients with resectable non-small cell lung cancer, as seen in the CheckMate 816 trial.
Patrick Forde, MBBCh, shares...
06/05/2025
APP Institute Oncology
Phuong Vo, MSN, RN, OCN, MEDSURG-BC
Videos
Impact of a Simulation-Based Training on Management of Infusion-Related Hypersensitivity
05/20/2025
Phuong Vo, MSN, RN, OCN, MEDSURG-BC
At the 2025 ONS Congress, Phuong Vo, MSN, RN, OCN, MEDSURG-BC shares the development and impact of a high-fidelity simulation training for hypersensitivity reaction preparedness among newly hired infusion nurses.
At the 2025 ONS Congress, Phuong Vo, MSN, RN, OCN, MEDSURG-BC shares the development and impact of a high-fidelity simulation training for hypersensitivity reaction preparedness among newly hired infusion nurses.
At the 2025 ONS Congress, Phuong...
05/20/2025
APP Institute Oncology
Fabienne Gaillard Ulysse, DNP, AOCNP, ANP-BC, FAAN
Conference Coverage
Community Education Program Improves Patient Education and Cancer Screening Rates
05/07/2025
Fabienne Gaillard Ulysse, DNP, AOCNP, ANP-BC, FAAN shares the impact of a community education program designed to increase cancer screening rates among New York residents.
Fabienne Gaillard Ulysse, DNP, AOCNP, ANP-BC, FAAN shares the impact of a community education program designed to increase cancer screening rates among New York residents.
Fabienne Gaillard Ulysse, DNP,...
05/07/2025
APP Institute Oncology
Jennifer Stephens MA, PhD, RN, OCN, CCNE
Conference Coverage
Exploring the Phenomenon of “Cancer Ghosting”
05/07/2025
Jennifer Stephens, MA, PhD, RN, OCN, CCNE
Jennifer Stephens MA, PhD, RN, OCN, CCNE, discusses results from a netnographic study which explored the phenomenon of “cancer ghosting.”
Jennifer Stephens MA, PhD, RN, OCN, CCNE, discusses results from a netnographic study which explored the phenomenon of “cancer ghosting.”
Jennifer Stephens MA, PhD, RN,...
05/07/2025
APP Institute Oncology
Nicole Ferreira, MSN, RN, NPD-BC, BMTCN, OCN
Videos
Development of Oncology Fellowship Providing Specialized Education for Newly Registered Nurses
05/05/2025
At the 2025 ONS Congress, Nicole Ferreira, MSN, RN, NPD-BC, BMTCN, OCN shares the development of an oncology fellowship program aimed to improve specialized practitioner education and competence as well as decrease practice turnover.
At the 2025 ONS Congress, Nicole Ferreira, MSN, RN, NPD-BC, BMTCN, OCN shares the development of an oncology fellowship program aimed to improve specialized practitioner education and competence as well as decrease practice turnover.
At the 2025 ONS Congress, Nicole...
05/05/2025
APP Institute Oncology
Robert Bennett, PhD, RN, PPCNP-BC, CPNP-AC
Conference Coverage
Value of Social Support and Symbols of Hope Among Hispanic Adolescent and Young Adult Survivors of Cancer
05/01/2025
Robert Bennett, PhD, PPCNP-BC, CPNP-AC
Robert Bennett, PhD, RN, PPCNP-BC, CPNP-AC, discusses a study aiming to determine symbols of hope as described by Hispanic adolescent and young adult survivors of cancer.
Robert Bennett, PhD, RN, PPCNP-BC, CPNP-AC, discusses a study aiming to determine symbols of hope as described by Hispanic adolescent and young adult survivors of cancer.
Robert Bennett, PhD, RN,...
05/01/2025
APP Institute Oncology
Jamie Myers, PhD, RN, AOCNS, FAAN
Conference Coverage
Assessment of Cognitive Function of Cancer Survivors With a Mobile Digital App
05/01/2025
Jamie Myers, PhD, RN, AOCNS, FAAN
Jamie Myers, PhD, RN, AOCNS, FAAN, discusses the evaluation of a mobile digital application, MindCap, to assess the cognitive function of cancer survivors.
Jamie Myers, PhD, RN, AOCNS, FAAN, discusses the evaluation of a mobile digital application, MindCap, to assess the cognitive function of cancer survivors.
Jamie Myers, PhD, RN, AOCNS,...
05/01/2025
APP Institute Oncology
Maureen O’Brien, CNS
Conference Coverage
Tobacco Treatment Training-Oncology Provides Nurses With Experimental and Evidence-Based Training
05/01/2025
Maureen O'Brien, CNS
Maureen O’Brien, CNS, outlines the tobacco treatment training-oncology, a 2-day workshop that aims to provide oncology nurses with relevant skills for management tobacco use and tobacco dependence among patients.
Maureen O’Brien, CNS, outlines the tobacco treatment training-oncology, a 2-day workshop that aims to provide oncology nurses with relevant skills for management tobacco use and tobacco dependence among patients.
Maureen O’Brien, CNS, outlines...
05/01/2025
APP Institute Oncology
Deborah Christensen, MSN, APRN, AOCNS
Videos
Implementation of a Virtual Oncology Navigation Model to Improve Patient Access
04/30/2025
Deborah Christensen, MSN, APRN
At the Oncology Nursing Society Congress, Deborah Christensen, MSN, APRN, AOCNS shares the development of a virtual oncology navigation model designed to improve patient access to cancer care.
At the Oncology Nursing Society Congress, Deborah Christensen, MSN, APRN, AOCNS shares the development of a virtual oncology navigation model designed to improve patient access to cancer care.
At the Oncology Nursing Society...
04/30/2025
APP Institute Oncology
APP Institute Oncology

The Advanced Practice Provider (APP) Institute is a new offering from the Oncology Learning Network that provides microburst education to oncology advanced practitioners. The platform offers year-round digital non-accredited learning modules through animated short videos, multimedia interviews with key opinion leaders, interactive content to test your knowledge, and more!

 

December 18-19, 2025 | Register Now

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use